Digoxigenin

Digoxigenin

SCHEMBL4994463

CC12CCC(O)CC1CCC1C2CC(O)C2(C)C(C3=CC(=O)OC3)CCC12O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 6/20 1.00
▸ PAX8 Q06710 4/20 1.00
▸ LMNA P02545 4/20 1.00
▸ SMN1; SMN2 Q16637 4/20 1.00
▸ RAB9A P51151 4/20 1.00
▸ HIF1A Q16665 3/20 1.00
▸ NPC1 O15118 3/20 1.00
▸ CYP2C19 P33261 2/20 1.00
▸ HSD17B10 Q99714 1/20 1.00
▸ SLCO4C1 Q6ZQN7 1/20 1.00
▸ ATP1A1 P05023 9/20 0.74
▸ ATP1B1 P05026 9/20 0.74
▸ ATP1B2 P14415 9/20 0.74
▸ ATP1A2 P50993 9/20 0.74
▸ ATP1B3 P54709 9/20 0.74
▸ TSHR P16473 2/20 0.74
▸ ATP1A3 P13637 2/20 0.74
▸ FXYD2 P54710 2/20 0.74
▸ ATP1A4 Q13733 2/20 0.74
▸ CYP3A4 P08684 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Digoxigenin SCHEMBL13337910 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL8816469 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL21105 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL24012132 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL13362000 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL23827178 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL12841138 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL11077489 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL8816474 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A
Digoxigenin SCHEMBL29477343 1.00 TP53 (1.00) TP53PAX8LMNASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681504-B1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN INC (US) 2023-08-23 — — EP disclosed
US-11573224-B2 Methods of detection using X-ray fluorescence ICAGEN, LLC (US) 2023-02-07 — — US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 — — US disclosed
US-10877035-B2 Advanced drug development and manufacturing ICAGEN, LLC (US) 2020-12-29 — — US disclosed
US-20200278346-A1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ADJACENT ACQUISITION CO., LLC 2020-09-03 — — US disclosed
WO-2020020728-A1 17BETA-HETEROCYCLYL-DIGITALIS LIKE COMPOUNDS FOR THE TREATMENT OF HEART FAILURE UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA (IT) 2020-01-30 — — WO disclosed
EP-3599243-A1 17BETA-HETEROCYCLYL-DIGITALIS LIKE COMPOUNDS FOR THE TREATMENT OF HEART FAILURE CVIE Therapeutics Limited (TW) 2020-01-29 — — EP disclosed
WO-2018122043-A1 NOVEL BIOTIN-SPECIFIC MONOCLONAL ANTIBODY AND USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2018-07-05 — — WO disclosed
US-20150309021-A1 Advanced Drug Development and Manufacturing LOS ALAMOS NATIONAL SECURITY, LLC 2015-10-29 — — US disclosed
EP-2511844-B1 X-ray microscope XRPRO SCIENCES INC (US) 2015-08-12 — — EP disclosed
EP-2511844-A2 Advanced drug development and manufacturing Los Alamos National Security, LLC (US) 2012-10-17 — — EP disclosed
EP-2084519-B1 X-RAY FLUORESCENCE ANALYSIS METHOD LOS ALAMOS NAT SECURITY LLC (US) 2012-08-01 — — EP disclosed
EP-0710667-B1 Modified oligonucleotides, their preparation and their use ROCHE DIAGNOSTICS GMBH (DE) 2011-12-14 — — EP disclosed
US-7635571-B2 photosenstizer generates singlet oxygen which oxidatively cleaves the linker to form a product which can be detected in a sandwich detection assay; kits SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH (DE) 2009-12-22 — — US disclosed
US-7635571-B2 photosenstizer generates singlet oxygen which oxidatively cleaves the linker to form a product which can be detected in a sandwich detection assay; kits SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH (DE) 2009-12-22 — — US disclosed
US-20080220441-A1 Advanced drug development and manufacturing THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-09-11 — — US disclosed
Send feedback